{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:05:10Z","timestamp":1784610310490,"version":"3.55.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Male hypogonadism is associated with significant alterations in body composition, including reduced lean body mass (LBM), increased fat body mass (FBM), particularly visceral adiposity, and impaired muscle function, contributing to frailty and cardiometabolic risk. These changes reflect the disruption of a complex endocrine crosstalk among bone, muscle, and adipose tissue, mediated by cytokines such as osteokines, myokines, and adipokines. This dysregulation promotes the development of osteosarcopenic obesity, a condition characterized by the coexistence of low bone mass, sarcopenia, and excess adiposity. Testosterone (T) plays a central role in maintaining body composition by stimulating muscle protein synthesis, inhibiting adipogenesis, and preserving bone health. Its deficiency, irrespective of etiology, leads to rapid impairment of anabolic pathways, resulting in decreased lean mass and increased fat accumulation. Evidence from clinical and experimental models demonstrates that these alterations are partially reversible with T replacement therapy (TRT), although variability exists depending on the underlying cause of hypogonadism. Dual-energy X-ray absorptiometry (DXA) represents the gold standard for assessing bone mineral density (BMD) and a key tool for evaluating body composition through a three-compartment model. It allows precise quantification of fat and lean mass, as well as their regional distribution, with minimal radiation exposure. In this review, we provide a comprehensive and clinically oriented overview of body composition alterations in male hypogonadism, focusing on underlying pathophysiological mechanisms and the practical application of DXA across different clinical scenarios. We discuss evidence from conditions such as Klinefelter syndrome, Kallmann syndrome, androgen deprivation therapy, HIV infection, and transgender care, aiming to offer a pragmatic framework for integrating body composition assessment into routine practice and improving patient management.<\/jats:p>","DOI":"10.1007\/s11154-026-10054-5","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:49:51Z","timestamp":1779677391000},"page":"875-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Body composition in male hypogonadism: practical considerations to the use of dual-energy x-ray absorptiometry"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-3451","authenticated-orcid":false,"given":"Andrea","family":"Delbarba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6112-8239","authenticated-orcid":false,"given":"Myriam","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9288-6261","authenticated-orcid":false,"given":"Walter","family":"Vena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2658-744X","authenticated-orcid":false,"given":"Biagio","family":"Cangiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0556-7650","authenticated-orcid":false,"given":"Emanuele","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1664-6183","authenticated-orcid":false,"given":"Alessandro","family":"Pizzocaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7209-8533","authenticated-orcid":false,"given":"Alessandro","family":"Chil\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4569-6561","authenticated-orcid":false,"given":"Marilina","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6078-2410","authenticated-orcid":false,"given":"Valeria","family":"Lanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9271-6388","authenticated-orcid":false,"given":"Caterina","family":"Buoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-871X","authenticated-orcid":false,"given":"Giorgio","family":"Tiecco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3444-2489","authenticated-orcid":false,"given":"Matteo","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3956-0043","authenticated-orcid":false,"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-701X","authenticated-orcid":false,"given":"Gherardo","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5817-8141","authenticated-orcid":false,"given":"Alberto","family":"Ferlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-6074","authenticated-orcid":false,"given":"Marco","family":"Bonomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"10054_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-009-0369-7","author":"A Andreoli","year":"2009","unstructured":"Andreoli A, Scalzo G, Masala S, Tarantino U, Guglielmi G. Body composition assessment by dual-energy X-ray absorptiometry (DXA). Radiol Med. 2009. https:\/\/doi.org\/10.1007\/s11547-009-0369-7.","journal-title":"Radiol Med"},{"key":"10054_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-020-00599-y","author":"B Kirk","year":"2020","unstructured":"Kirk B, Feehan J, Lombardi G, Duque G. Muscle, bone, and fat crosstalk: the biological role of myokines, osteokines, and adipokines. Curr Osteoporos Rep. 2020. https:\/\/doi.org\/10.1007\/s11914-020-00599-y.","journal-title":"Curr Osteoporos Rep"},{"key":"10054_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2016.10.003","author":"F Li","year":"2017","unstructured":"Li F, Li Y, Duan Y, Hu CAA, Tang Y, Yin Y. Myokines and adipokines: involvement in the crosstalk between skeletal muscle and adipose tissue. Cytokine Growth Factor Rev. 2017. https:\/\/doi.org\/10.1016\/j.cytogfr.2016.10.003.","journal-title":"Cytokine Growth Factor Rev"},{"key":"10054_CR4","doi-asserted-by":"publisher","unstructured":"Hiruma E. Muscles and bones. in Osteosarcopenia. Elsevier; 2022. pp. 1\u201318. https:\/\/doi.org\/10.1016\/B978-0-12-820088-9.00021-4.","DOI":"10.1016\/B978-0-12-820088-9.00021-4"},{"key":"10054_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2025.101367","author":"AM Malvandi","year":"2025","unstructured":"Malvandi AM, Gerosa L, Banfi G, Lombardi G. The bone-muscle unit: from mechanical coupling to soluble factors-mediated signaling. Mol Aspects Med. 2025. https:\/\/doi.org\/10.1016\/j.mam.2025.101367.","journal-title":"Mol Aspects Med"},{"key":"10054_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-023-01093-0","author":"A Shimonty","year":"2023","unstructured":"Shimonty A, Bonewald LF, Huot JR. Metabolic health and disease: a role of osteokines? Calcif Tissue Int. 2023. https:\/\/doi.org\/10.1007\/s00223-023-01093-0.","journal-title":"Calcif Tissue Int"},{"key":"10054_CR7","doi-asserted-by":"publisher","DOI":"10.1210\/ENDREV\/BNAA016","author":"MCK Severinsen","year":"2020","unstructured":"Severinsen MCK, Pedersen BK. Muscle\u2013organ crosstalk: the emerging roles of myokines. Endocr Soc. 2020. https:\/\/doi.org\/10.1210\/ENDREV\/BNAA016.","journal-title":"Endocr Soc"},{"key":"10054_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.043","author":"G Karsenty","year":"2016","unstructured":"Karsenty G, Olson EN. Bone and muscle endocrine functions: unexpected paradigms of inter-organ communication. Cell. 2016. https:\/\/doi.org\/10.1016\/j.cell.2016.02.043.","journal-title":"Cell"},{"key":"10054_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/nature10763","author":"G Karsenty","year":"2012","unstructured":"Karsenty G, Ferron M. The contribution of bone to whole-organism physiology. Nature. 2012. https:\/\/doi.org\/10.1038\/nature10763.","journal-title":"Nature"},{"key":"10054_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115053","author":"JA Kim","year":"2019","unstructured":"Kim JA, et al. Association of serum sclerostin levels with low skeletal muscle mass: the Korean Sarcopenic Obesity Study (KSOS). Bone. 2019. https:\/\/doi.org\/10.1016\/j.bone.2019.115053.","journal-title":"Bone"},{"key":"10054_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2012.49","author":"BK Pedersen","year":"2012","unstructured":"Pedersen BK, Febbraio MA. \u201cMuscles, exercise and obesity: skeletal muscle as a secretory organ,.\u201d Nat Rev Endocrinol. 2012. https:\/\/doi.org\/10.1038\/nrendo.2012.49.","journal-title":"Nat Rev Endocrinol"},{"key":"10054_CR12","doi-asserted-by":"publisher","unstructured":"de Dos Santos AR et al. Adipokines, myokines, and hepatokines: Crosstalk and metabolic repercussions. 2021 MDPI AG. https:\/\/doi.org\/10.3390\/ijms22052639","DOI":"10.3390\/ijms22052639"},{"key":"10054_CR13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607501103","author":"BJ Feldman","year":"2006","unstructured":"Feldman BJ, Streeper RS, Farese RV, Yamamoto KR. Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci U S A. 2006. https:\/\/doi.org\/10.1073\/pnas.0607501103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10054_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/pedi.12964","volume":"21","author":"C Frithioff-B\u00f8js\u00f8e","year":"2020","unstructured":"Frithioff-B\u00f8js\u00f8e C, et al. Leptin, adiponectin, and their ratio as markers of insulin resistance and cardiometabolic risk in childhood obesity. Pediatr Diabetes. 2020;21(2):194\u2013202. https:\/\/doi.org\/10.1111\/pedi.12964.","journal-title":"Pediatr Diabetes"},{"issue":"12","key":"10054_CR15","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1210\/en.2004-0503","volume":"145","author":"AM Delaigle","year":"2004","unstructured":"Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM. Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology. 2004;145(12):5589\u201397. https:\/\/doi.org\/10.1210\/en.2004-0503.","journal-title":"Endocrinology"},{"key":"10054_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1152\/ajpendo.00506.2005.-Obesity","volume":"290","author":"JM Bruun","year":"2006","unstructured":"Bruun JM, Helge JW, Richelsen B, Stallknecht B, Bruun JM. \u201cDiet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects,.\u201d Am J Physiol Endocrinol Metab. 2006;290:961\u20137. https:\/\/doi.org\/10.1152\/ajpendo.00506.2005.-Obesity.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10054_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2014.02.007","author":"JZ Ilich","year":"2014","unstructured":"Ilich JZ, Kelly OJ, Inglis JE, Panton LB, Duque G, Ormsbee MJ. \u201cInterrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels,.\u201d Ageing Res Rev. 2014. https:\/\/doi.org\/10.1016\/j.arr.2014.02.007.","journal-title":"Ageing Res Rev"},{"key":"10054_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/nu12040989","author":"JZ Ilich","year":"2020","unstructured":"Ilich JZ, Gilman JC, Cvijetic S, Boschiero D. Chronic stress contributes to osteosarcopenic adiposity via inflammation and immune modulation: the case for more precise nutritional investigation. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12040989.","journal-title":"Nutrients"},{"key":"10054_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7325973","author":"JZ Ilich","year":"2016","unstructured":"Ilich JZ, Kelly OJ, Inglis JE. Osteosarcopenic obesity syndrome: what is it and how can it be identified and diagnosed? Curr Gerontol Geriatr Res. 2016. https:\/\/doi.org\/10.1155\/2016\/7325973.","journal-title":"Curr Gerontol Geriatr Res"},{"key":"10054_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040747","author":"OJ Kelly","year":"2019","unstructured":"Kelly OJ, Gilman JC, Boschiero D, Ilich JZ. Osteosarcopenic obesity: current knowledge, revised identification criteria and treatment principles. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11040747.","journal-title":"Nutrients"},{"key":"10054_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13101056","author":"K Hu","year":"2023","unstructured":"Hu K, et al. Understanding the consequences of fatty bone and fatty muscle: how the osteosarcopenic adiposity phenotype uncovers the deterioration of body composition. Metabolites. 2023. https:\/\/doi.org\/10.3390\/metabo13101056.","journal-title":"Metabolites"},{"key":"10054_CR22","doi-asserted-by":"publisher","unstructured":"Bauer JM et al. Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review, 2019, Springer New York LLC. https:\/\/doi.org\/10.1007\/s00223-019-00561-w","DOI":"10.1007\/s00223-019-00561-w"},{"key":"10054_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/nu15071619","author":"V Vucic","year":"2023","unstructured":"Vucic V, et al. Nutrition and physical activity as modulators of osteosarcopenic adiposity: a scoping review and recommendations for future research. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15071619.","journal-title":"Nutrients"},{"key":"10054_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/nu14091816","author":"L Di Filippo","year":"2022","unstructured":"Di Filippo L, De Lorenzo R, Giustina A, Rovere-Querini P, Conte C. Vitamin D in osteosarcopenic obesity. MDPI. 2022. https:\/\/doi.org\/10.3390\/nu14091816.","journal-title":"MDPI"},{"key":"10054_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-023-01247-5","author":"Y Liu","year":"2023","unstructured":"Liu Y, Song Y, Hao Q, Wu J. Global prevalence of osteosarcopenic obesity amongst middle aged and older adults: a systematic review and meta-analysis. Arch Osteoporos. 2023. https:\/\/doi.org\/10.1007\/s11657-023-01247-5.","journal-title":"Arch Osteoporos"},{"key":"10054_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-023-07007-y","author":"Y Liu","year":"2024","unstructured":"Liu Y, Hao Q, Zhou J, Wu J. A comprehensive meta-analysis of risk factors associated with osteosarcopenic obesity: a closer look at gender, lifestyle and comorbidities. Osteoporos Int. 2024. https:\/\/doi.org\/10.1007\/s00198-023-07007-y.","journal-title":"Osteoporos Int"},{"key":"10054_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12567","author":"B Kirk","year":"2020","unstructured":"Kirk B, Zanker J, Duque G. Osteosarcopenia: epidemiology, diagnosis, and treatment\u2014facts and numbers. J Cachexia Sarcopenia Muscle. 2020. https:\/\/doi.org\/10.1002\/jcsm.12567.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10054_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156052","author":"R Conforto","year":"2024","unstructured":"Conforto R, et al. Advances in body composition and gender differences in susceptibility to frailty syndrome: role of osteosarcopenic obesity. Metabolism. 2024. https:\/\/doi.org\/10.1016\/j.metabol.2024.156052.","journal-title":"Metabolism"},{"key":"10054_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jor.2024.03.039","author":"HW Liu","year":"2024","unstructured":"Liu HW, Lee OKS. Effects of resistance training with elastic bands on bone mineral density, body composition, and osteosarcopenic obesity in elderly women: a meta-analysis. J Orthop. 2024. https:\/\/doi.org\/10.1016\/j.jor.2024.03.039.","journal-title":"J Orthop"},{"key":"10054_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15189","author":"R Zhang","year":"2025","unstructured":"Zhang R, et al. Body composition, adipocytokine, and metabolic parameters in men with congenital hypogonadotropic hypogonadism. Clin Endocrinol (Oxf). 2025. https:\/\/doi.org\/10.1111\/cen.15189.","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"10054_CR31","doi-asserted-by":"publisher","unstructured":"Grande G, Graziani A, Di Mambro A, Selice R, Ferlin A. Osteoporosis and bone metabolism in patients with klinefelter syndrome, 2023. https:\/\/doi.org\/10.1530\/EC-23-0058","DOI":"10.1530\/EC-23-0058"},{"key":"10054_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206202","author":"K Shigehara","year":"2022","unstructured":"Shigehara K, Kato Y, Izumi K, Mizokami A. Relationship between testosterone and sarcopenia in older-adult men: a narrative review. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11206202.","journal-title":"J Clin Med"},{"key":"10054_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/bf03346513","author":"D Fintini","year":"2009","unstructured":"Fintini D, et al. Bone mineral density and body composition in male children with hypogonadism. J Endocrinol Invest. 2009. https:\/\/doi.org\/10.1007\/bf03346513.","journal-title":"J Endocrinol Invest"},{"key":"10054_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2004.01.004","author":"S Mudali","year":"2004","unstructured":"Mudali S, Dobs AS. Effects of testosterone on body composition of the aging male. Mech Ageing Dev. 2004. https:\/\/doi.org\/10.1016\/j.mad.2004.01.004.","journal-title":"Mech Ageing Dev"},{"key":"10054_CR35","doi-asserted-by":"publisher","unstructured":"Petry C, Minuzzi RK, dos Santos FS, Semmelmann AL, Bassols GF, Lima JFSP. Evaluation of the Impact of Functional Hypogonadism in Body Composition and Weight Loss in Men Undergoing Bariatric Surgery. Obes Surg. 2025;35(1). https:\/\/doi.org\/10.1007\/s11695-024-07626-2.","DOI":"10.1007\/s11695-024-07626-2"},{"key":"10054_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1938548","author":"G Corona","year":"2021","unstructured":"Corona G, et al. \u201cThe role of testosterone treatment in patients with metabolic disorders,.\u201d Expert Rev Clin Pharmacol. 2021. https:\/\/doi.org\/10.1080\/17512433.2021.1938548.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10054_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1426175","author":"S Bathina","year":"2024","unstructured":"Bathina S, Colleluori G, Villareal DT, Aguirre L, Chen R, Armamento-Villareal R. A PRDM16-driven signal regulates body composition in testosterone-treated hypogonadal men. Front Endocrinol. 2024. https:\/\/doi.org\/10.3389\/fendo.2024.1426175.","journal-title":"Front Endocrinol"},{"key":"10054_CR38","doi-asserted-by":"crossref","unstructured":"Saad F, Aversa A, Isidori AM, Gooren LJ. Testosterone as Potential Effective Therapy in Treatment of Obesity in Men with Testosterone Deficiency. A Review; 2012.","DOI":"10.2174\/157339912799424573"},{"issue":"1","key":"10054_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/jc.2007-1291","volume":"93","author":"CA Allan","year":"2008","unstructured":"Allan CA, Strauss BJG, Burger HG, Forbes EA, McLachlan RI. \u201cTestosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men,.\u201d J Clin Endocrinol Metab. 2008;93(1):139\u201346. https:\/\/doi.org\/10.1210\/jc.2007-1291.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10054_CR40","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3275\/6903","volume":"33","author":"A Aversa","year":"2010","unstructured":"Aversa A, Bruzziches R, Francomano D, Spera G, Lenzi A. Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome. J Endocrinol Invest. 2010;33(11):776\u201383. https:\/\/doi.org\/10.3275\/6903.","journal-title":"J Endocrinol Invest"},{"key":"10054_CR41","doi-asserted-by":"publisher","unstructured":"Dhindsa S, et al. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction after Testosterone Replacement in Men with Type 2 Diabetes. Diabetes Care. 2016;39(1):82\u201391. https:\/\/doi.org\/10.2337\/dc15-1518.","DOI":"10.2337\/dc15-1518"},{"issue":"5","key":"10054_CR42","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1365-2265.2010.03845.x","volume":"73","author":"SY Kalinchenko","year":"2010","unstructured":"Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJG, Giltay EJ, Saad F. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol. 2010;73(5):602\u201312. https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03845.x.","journal-title":"Clin Endocrinol"},{"key":"10054_CR43","unstructured":"Corona G et al. TITLE Testosterone supplementation and body composition: results from a meta-analysis 1 study. 2 SHORT TITLE: Body composition. metabolism Testosterone 3 4, 2015."},{"issue":"1","key":"10054_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","volume":"9","author":"G Wittert","year":"2021","unstructured":"Wittert G, et al. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol. 2021;9(1):32\u201345. https:\/\/doi.org\/10.1016\/S2213-8587(20)30367-3.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10054_CR45","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1530\/eje.1.02166","volume":"154","author":"D Kapoor","year":"2006","unstructured":"Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006;154(6):899\u2013906. https:\/\/doi.org\/10.1530\/eje.1.02166.","journal-title":"Eur J Endocrinol"},{"key":"10054_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.915309","author":"FNU Deepika","year":"2022","unstructured":"Deepika FNU, et al. Baseline testosterone predicts body composition and metabolic response to testosterone therapy. Front Endocrinol (Lausanne). 2022. https:\/\/doi.org\/10.3389\/fendo.2022.915309.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10054_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2024.04.005","author":"RK Minuzzi","year":"2024","unstructured":"Minuzzi RK, Petry C, Souza dos Santos F, Semmelmann AL, Bassols GF, Pereira-Lima JFS. The role of hypogonadism in the body composition of obese men in the preoperative period of bariatric surgery. Endocr Pract. 2024. https:\/\/doi.org\/10.1016\/j.eprac.2024.04.005.","journal-title":"Endocr Pract"},{"key":"10054_CR48","doi-asserted-by":"publisher","unstructured":"Spaziani M et al. Extra-Gonadal and Non-Canonical Effects of FSH in Males, Jun. 01, 2023, Multidisciplinary Digital Publishing Institute (MDPI). https:\/\/doi.org\/10.3390\/ph16060813","DOI":"10.3390\/ph16060813"},{"key":"10054_CR49","doi-asserted-by":"publisher","unstructured":"Giovanelli L, et al. FSH and bone: Comparison between males with central versus primary hypogonadism. Front Endocrinol (Lausanne). 2022;13. https:\/\/doi.org\/10.3389\/fendo.2022.939897.","DOI":"10.3389\/fendo.2022.939897"},{"key":"10054_CR50","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf565","author":"C Buoso","year":"2025","unstructured":"Buoso C, et al. \u201cBody composition by DXA in patients with Klinefelter and Kallmann syndrome: the Kama study,.\u201d J Clin Endocrinol Metab. 2025. https:\/\/doi.org\/10.1210\/clinem\/dgaf565.","journal-title":"J Clin Endocrinol Metab"},{"key":"10054_CR51","doi-asserted-by":"publisher","DOI":"10.2174\/0929866527666200925105739","author":"P Facondo","year":"2020","unstructured":"Facondo P, Delbarba A, Maffezzoni F, Cappelli C, Ferlin A. INSL3: A marker of Leydig cell function and testis-bone-skeletal muscle network. Protein Pept Lett. 2020. https:\/\/doi.org\/10.2174\/0929866527666200925105739.","journal-title":"Protein Pept Lett"},{"key":"10054_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.135","author":"A Ferlin","year":"2013","unstructured":"Ferlin A, Selice R, Carraro U, Foresta C. \u201cTesticular function and bone metabolism - beyond testosterone,.\u201d Nat Rev Endocrinol. 2013. https:\/\/doi.org\/10.1038\/nrendo.2013.135.","journal-title":"Nat Rev Endocrinol"},{"key":"10054_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092522","author":"A Gonera-Furman","year":"2022","unstructured":"Gonera-Furman A, Bolanowski M, J\u0119drzejuk D. Osteosarcopenia\u2014the role of dual-energy X-ray absorptiometry (DXA) in diagnostics. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11092522.","journal-title":"J Clin Med"},{"key":"10054_CR54","doi-asserted-by":"publisher","unstructured":"Asmar N et al. Dual-Energy X-ray Absorptiometry in Osteoporosis and Osteopenia: Imaging Interpretation and Pitfalls, 2025. https:\/\/doi.org\/10.1148\/rg.240193","DOI":"10.1148\/rg.240193"},{"key":"10054_CR55","doi-asserted-by":"publisher","unstructured":"Slart RHJA et al. Updated practice guideline for dual-energy X-ray absorptiometry (DXA), 2025, Springer. https:\/\/doi.org\/10.1007\/s00259-024-06912-6","DOI":"10.1007\/s00259-024-06912-6"},{"issue":"8","key":"10054_CR56","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.ejrad.2016.04.004","volume":"85","author":"A Bazzocchi","year":"2016","unstructured":"Bazzocchi A, Ponti F, Albisinni U, Battista G, Guglielmi G. DXA: technical aspects and application. Eur J Radiol. 2016;85(8):1481\u201392. https:\/\/doi.org\/10.1016\/j.ejrad.2016.04.004.","journal-title":"Eur J Radiol"},{"key":"10054_CR57","unstructured":"Assessment of fracture. risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group., 1994."},{"key":"10054_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2019.07.001","author":"CR Shuhart","year":"2019","unstructured":"Shuhart CR, et al. Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom. 2019. https:\/\/doi.org\/10.1016\/j.jocd.2019.07.001.","journal-title":"J Clin Densitom"},{"issue":"5","key":"10054_CR59","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/oby.2011.367","volume":"20","author":"LK Micklesfield","year":"2012","unstructured":"Micklesfield LK, Goedecke JH, Punyanitya M, Wilson KE, Kelly TL. Dual-energy X-ray performs as well as clinical computed tomography for the measurement of visceral fat. Obesity. 2012;20(5):1109\u201314. https:\/\/doi.org\/10.1038\/oby.2011.367.","journal-title":"Obesity"},{"key":"10054_CR60","doi-asserted-by":"publisher","DOI":"10.21037\/QIMS.2020.03.02","author":"C Messina","year":"2020","unstructured":"Messina C, et al. Body composition with dual energy X-ray absorptiometry: From basics to new tools. Aug 01. 2020. https:\/\/doi.org\/10.21037\/QIMS.2020.03.02. AME Publishing Company.","journal-title":"Aug 01"},{"key":"10054_CR61","doi-asserted-by":"publisher","unstructured":"Cruz-Jentoft AJ et al. Sarcopenia: Revised European consensus on definition and diagnosis, Jan. 01, 2019, Oxford University Press. https:\/\/doi.org\/10.1093\/ageing\/afy169","DOI":"10.1093\/ageing\/afy169"},{"issue":"3","key":"10054_CR62","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000521241","volume":"15","author":"LM Donini","year":"2022","unstructured":"Donini LM, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15(3):321\u201335. https:\/\/doi.org\/10.1159\/000521241.","journal-title":"Obes Facts"},{"key":"10054_CR63","doi-asserted-by":"publisher","unstructured":"Studenski SA et al. The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates, Journals of Gerontology - Series A Biological Sciences and Medical Sciences, vol. 69 A, no. 5, pp. 547\u2013558, 2014, https:\/\/doi.org\/10.1093\/gerona\/glu010","DOI":"10.1093\/gerona\/glu010"},{"issue":"4","key":"10054_CR64","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00223-013-9830-7","volume":"94","author":"H Gould","year":"2014","unstructured":"Gould H, Brennan SL, Kotowicz MA, Nicholson GC, Pasco JA. Total and appendicular lean mass reference ranges for Australian men and women: the Geelong osteoporosis study,. Calcif Tissue Int. 2014;94(4):363\u201372. https:\/\/doi.org\/10.1007\/s00223-013-9830-7.","journal-title":"Calcif Tissue Int"},{"key":"10054_CR65","doi-asserted-by":"crossref","unstructured":"Janssen I, Heymsfield SB, Ross R. Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability, 2002.","DOI":"10.1046\/j.1532-5415.2002.50216.x"},{"key":"10054_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12260","author":"JA Batsis","year":"2013","unstructured":"Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez-Jimenez F, Bartels SJ. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: Dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999\u20132004. J Am Geriatr Soc. 2013. https:\/\/doi.org\/10.1111\/jgs.12260.","journal-title":"J Am Geriatr Soc"},{"key":"10054_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/72.3.694","author":"D Gallagher","year":"2000","unstructured":"Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000. https:\/\/doi.org\/10.1093\/ajcn\/72.3.694.","journal-title":"Am J Clin Nutr"},{"key":"10054_CR68","doi-asserted-by":"crossref","unstructured":"Genant HK, C. Y. Wu,\u2019 Cornelis Van Kuijk,\u2019 Arid, and, Nevitt\u2019 MC. Vertebral Fracture Assessment Using a Semiquantitative Technique, 1993.","DOI":"10.1002\/jbmr.5650080915"},{"key":"10054_CR69","doi-asserted-by":"publisher","unstructured":"McCloskey EV, et al. A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX. J Bone Miner Res. May 2016;31(5):940\u20138. https:\/\/doi.org\/10.1002\/jbmr.2734.","DOI":"10.1002\/jbmr.2734"},{"issue":"9","key":"10054_CR70","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00198-023-06817-4","volume":"34","author":"E Shevroja","year":"2023","unstructured":"Shevroja E, et al. Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging. Osteoporos Int. 2023;34(9):1501\u201329. https:\/\/doi.org\/10.1007\/s00198-023-06817-4.","journal-title":"Osteoporos Int"},{"key":"10054_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.590139","author":"FM Ulivieri","year":"2021","unstructured":"Ulivieri FM, Rinaudo L. Beyond bone mineral density: a new dual X-ray absorptiometry index of bone strength to predict fragility fractures, the bone strain index. Front Med. 2021. https:\/\/doi.org\/10.3389\/fmed.2020.590139.","journal-title":"Front Med"},{"key":"10054_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092284","author":"FM Ulivieri","year":"2022","unstructured":"Ulivieri FM, Rinaudo L. The bone strain index: an innovative dual X-ray absorptiometry bone strength index and its helpfulness in clinical medicine. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11092284.","journal-title":"J Clin Med"},{"key":"10054_CR73","doi-asserted-by":"publisher","unstructured":"Zitzmann M et al. European academy of andrology guidelines on Klinefelter Syndrome Endorsing Organization: European Society of Endocrinology. Jan 01 2021 Blackwell Publishing Ltd. https:\/\/doi.org\/10.1111\/andr.12909","DOI":"10.1111\/andr.12909"},{"key":"10054_CR74","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3032759","author":"S Stagi","year":"2016","unstructured":"Stagi S, et al. Bone mineral status in children and adolescents with Klinefelter syndrome. Int J Endocrinol. 2016. https:\/\/doi.org\/10.1155\/2016\/3032759.","journal-title":"Int J Endocrinol"},{"key":"10054_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01299-1","author":"A Pizzocaro","year":"2020","unstructured":"Pizzocaro A, et al. Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis. J Endocrinol Invest. 2020. https:\/\/doi.org\/10.1007\/s40618-020-01299-1.","journal-title":"J Endocrinol Invest"},{"key":"10054_CR76","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1878","author":"A Ferlin","year":"2011","unstructured":"Ferlin A, et al. Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism. J Clin Endocrinol Metab. 2011. https:\/\/doi.org\/10.1210\/jc.2010-1878.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10054_CR77","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/andr.12841","volume":"8","author":"W Vena","year":"2020","unstructured":"Vena W, et al. Prevalence and determinants of radiological vertebral fractures in patients with Klinefelter syndrome. Andrology. 2020;8(6):1699\u2013704. https:\/\/doi.org\/10.1111\/andr.12841.","journal-title":"Andrology"},{"key":"10054_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15301","author":"S Pigni","year":"2025","unstructured":"Pigni S, et al. Unraveling the puzzle of bone health in Klinefelter syndrome: association between DXA-derived Lumbar Bone Strain Index and body composition parameters in a single center cohort. Clin Endocrinol (Oxf). 2025. https:\/\/doi.org\/10.1111\/cen.15301.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10054_CR79","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1002\/jbmr.2272","volume":"29","author":"VV Shanbhogue","year":"2014","unstructured":"Shanbhogue VV, Hansen S, J\u00f8rgensen NR, Brixen K, Gravholt CH. Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in Klinefelter syndrome. J Bone Miner Res. 2014;29(11):2474\u201382. https:\/\/doi.org\/10.1002\/jbmr.2272.","journal-title":"J Bone Miner Res"},{"key":"10054_CR80","doi-asserted-by":"publisher","unstructured":"Vena W, et al. Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome. J Endocrinol Invest. Feb. 2023;46(2):297\u2013304. https:\/\/doi.org\/10.1007\/s40618-022-01901-8.","DOI":"10.1007\/s40618-022-01901-8"},{"key":"10054_CR81","unstructured":"Sonne J, Leslie SW. Kallmann Syndrome. and W. Lopez-Ojeda; 2025."},{"key":"10054_CR82","doi-asserted-by":"crossref","unstructured":"Finkelstein JS et al. Increases in Bone Density During Treatment of Men with Idiopathic Hypogonadotropic Hypogonadism*, 1989.","DOI":"10.1210\/jcem-69-4-776"},{"key":"10054_CR83","doi-asserted-by":"crossref","unstructured":"Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Long-Term Effect of Testosterone Therapy on Bone Mineral Density in Hypogonadal Men, 1997.","DOI":"10.1210\/jcem.82.8.4163"},{"key":"10054_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(96)00188-3","author":"HS Taylor","year":"1996","unstructured":"Taylor HS, Cass I, Lang R. Bone loss in Kallmann syndrome. Obstet Gynecol. 1996. https:\/\/doi.org\/10.1016\/0029-7844(96)00188-3.","journal-title":"Obstet Gynecol"},{"key":"10054_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/6328524","volume":"2017","author":"S Radi","year":"2017","unstructured":"Radi S, Karaplis AC. A case of male osteoporosis: a 37-year-old man with multiple vertebral compression fractures. Case Rep Endocrinol. 2017;2017:1\u20137. https:\/\/doi.org\/10.1155\/2017\/6328524.","journal-title":"Case Rep Endocrinol"},{"issue":"3","key":"10054_CR86","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/andr.12604","volume":"7","author":"L Antonio","year":"2019","unstructured":"Antonio L, Caerels S, Jardi F, Delaunay E, Vanderschueren D. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects. Andrology. 2019;7(3):302\u20136. https:\/\/doi.org\/10.1111\/andr.12604.","journal-title":"Andrology"},{"key":"10054_CR87","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40520-015-0421-5","volume":"27","author":"G Iolascon","year":"2015","unstructured":"Iolascon G, et al. Bone involvement in males with Kallmann disease. Aging Clin Exp Res. 2015;27:31\u20136. https:\/\/doi.org\/10.1007\/s40520-015-0421-5.","journal-title":"Aging Clin Exp Res"},{"key":"10054_CR88","doi-asserted-by":"publisher","unstructured":"Maione L, Colao A, Young J. Bone mineral density in older patients with never-treated congenital hypogonadotropic hypogonadism, Jan. 01, 2018, Humana Press Inc. https:\/\/doi.org\/10.1007\/s12020-017-1334-1","DOI":"10.1007\/s12020-017-1334-1"},{"issue":"4","key":"10054_CR89","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-2605.2011.01237.x","volume":"35","author":"EM Laitinen","year":"2012","unstructured":"Laitinen EM, Hero M, Vaaralahti K, Tommiska J, Raivio T. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism. Int J Androl. 2012;35(4):534\u201340. https:\/\/doi.org\/10.1111\/j.1365-2605.2011.01237.x.","journal-title":"Int J Androl"},{"key":"10054_CR90","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab169","author":"A Ostertag","year":"2021","unstructured":"Ostertag A, et al. Compromised volumetric bone density and microarchitecture in men with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2021. https:\/\/doi.org\/10.1210\/clinem\/dgab169.","journal-title":"J Clin Endocrinol Metab"},{"key":"10054_CR91","unstructured":"Magee DE, Singal RK. Androgen deprivation therapy: indications, methods of utilization, side effects and their management, 2020."},{"key":"10054_CR92","doi-asserted-by":"crossref","unstructured":"Cianferotti L et al. The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation, 2017. [Online]. Available: https:\/\/www.impactjournals.com\/oncotarget.","DOI":"10.18632\/oncotarget.17980"},{"issue":"11","key":"10054_CR93","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.ejso.2015.06.011","volume":"41","author":"F Abdollah","year":"2015","unstructured":"Abdollah F, et al. Medical androgen deprivation therapy and increased non-cancer mortality in non-metastatic prostate cancer patients aged\u2009\u2265\u200966 years. Eur J Surg Oncol. 2015;41(11):1529\u201339. https:\/\/doi.org\/10.1016\/j.ejso.2015.06.011.","journal-title":"Eur J Surg Oncol"},{"key":"10054_CR94","doi-asserted-by":"publisher","unstructured":"D\u2019Oronzo S, Stucci S, Tucci M, Silvestris F. Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications, Nov. 01, 2015, W.B. Saunders Ltd. https:\/\/doi.org\/10.1016\/j.ctrv.2015.09.003","DOI":"10.1016\/j.ctrv.2015.09.003"},{"key":"10054_CR95","doi-asserted-by":"publisher","unstructured":"Volta AD et al. Bone mineral density and frax score may not predict fracture risk in patients with cancer undergoing hormone deprivation therapies, Oct. 10, 2020, American Society of Clinical Oncology. https:\/\/doi.org\/10.1200\/JCO.20.00434","DOI":"10.1200\/JCO.20.00434"},{"key":"10054_CR96","doi-asserted-by":"publisher","unstructured":"Dalla Volta A et al. Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients, Oct. 01, 2023, Springer. https:\/\/doi.org\/10.1007\/s11912-023-01447-9","DOI":"10.1007\/s11912-023-01447-9"},{"key":"10054_CR97","doi-asserted-by":"publisher","unstructured":"Cianferotti L et al. Bone quality in endocrine diseases: determinants and clinical relevance, 2023. https:\/\/doi.org\/10.1007\/s40618-023-02056-w","DOI":"10.1007\/s40618-023-02056-w"},{"issue":"3","key":"10054_CR98","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jocd.2011.05.003","volume":"14","author":"S Sullivan","year":"2011","unstructured":"Sullivan S, Wagner J, Resnick NM, Nelson J, Perera SK, Greenspan SL. Vertebral fractures and the misclassification of osteoporosis in men with prostate cancer. J Clin Densitom. 2011;14(3):348\u201353. https:\/\/doi.org\/10.1016\/j.jocd.2011.05.003.","journal-title":"J Clin Densitom"},{"key":"10054_CR99","doi-asserted-by":"publisher","unstructured":"Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer,. N Engl J Med. 1984;311(20). https:\/\/doi.org\/10.1056\/nejm198411153112004.","DOI":"10.1056\/nejm198411153112004"},{"issue":"8","key":"10054_CR100","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s11547-024-01843-6","volume":"129","author":"C Messina","year":"2024","unstructured":"Messina C, et al. DXA beyond bone mineral density and the REMS technique: new insights for current radiologists practice. Radiol Med. 2024;129(8):1224\u201340. https:\/\/doi.org\/10.1007\/s11547-024-01843-6.","journal-title":"Radiol Med"},{"key":"10054_CR101","doi-asserted-by":"publisher","unstructured":"Shapiro CL et al. Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline,., 2019. [Online]. Available: https:\/\/doi.org\/10.1200\/JCO.19.01696.","DOI":"10.1200\/JCO.19.01696"},{"key":"10054_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64985-3","author":"A Berruti","year":"2002","unstructured":"Berruti A, et al. Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. J Urol. 2002. https:\/\/doi.org\/10.1016\/S0022-5347(05)64985-3.","journal-title":"J Urol"},{"issue":"1","key":"10054_CR103","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12020-015-0525-x","volume":"50","author":"C Buttigliero","year":"2015","unstructured":"Buttigliero C, et al. The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome. Endocrine. 2015;50(1):223\u201330. https:\/\/doi.org\/10.1007\/s12020-015-0525-x.","journal-title":"Endocrine"},{"key":"10054_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2022.100421","author":"G Mazziotti","year":"2022","unstructured":"Mazziotti G, et al. Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: reliability of WHO fracture risk assessment tool (FRAX) and bone mineral density in real-life clinical practice. J Bone Oncol. 2022. https:\/\/doi.org\/10.1016\/j.jbo.2022.100421.","journal-title":"J Bone Oncol"},{"key":"10054_CR105","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac489","author":"C Palumbo","year":"2022","unstructured":"Palumbo C, et al. Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade Study. Journal of Clinical Endocrinology and Metabolism. 2022. https:\/\/doi.org\/10.1210\/clinem\/dgac489.","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10054_CR106","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.7954","volume":"3","author":"JL Marcus","year":"2020","unstructured":"Marcus JL, et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000\u20132016. JAMA Netw Open. 2020;3(6):E207954. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.7954.","journal-title":"JAMA Netw Open"},{"key":"10054_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106898","author":"L Taramasso","year":"2023","unstructured":"Taramasso L, et al. Pillars of long-term antiretroviral therapy success. Pharmacol Res. 2023. https:\/\/doi.org\/10.1016\/j.phrs.2023.106898.","journal-title":"Pharmacol Res"},{"issue":"12","key":"10054_CR108","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1158\/1055-9965.EPI-11-0777","volume":"20","author":"MJ Silverberg","year":"2011","unstructured":"Silverberg MJ, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiology Biomarkers and Prevention. 2011;20(12):2551\u20139. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0777.","journal-title":"Cancer Epidemiology Biomarkers and Prevention"},{"key":"10054_CR109","doi-asserted-by":"crossref","unstructured":"Drozd DR et al. Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population, 2017. [Online]. Available: https:\/\/www.jaids.com.","DOI":"10.1097\/QAI.0000000000001450"},{"key":"10054_CR110","doi-asserted-by":"publisher","DOI":"10.1111\/andr.70050","author":"G Tiecco","year":"2025","unstructured":"Tiecco G, et al. Penile vascular status in young men living with HIV experiencing erectile dysfunction: a comparative cross-sectional pilot study,. Andrology. 2025. https:\/\/doi.org\/10.1111\/andr.70050.","journal-title":"Andrology"},{"key":"10054_CR111","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad136","author":"R Ron","year":"2023","unstructured":"Ron R, et al. CD4\/CD8 ratio during Human Immunodeficiency Virus treatment: time for routine monitoring? Clin Infect Dis. 2023. https:\/\/doi.org\/10.1093\/cid\/ciad136.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10054_CR112","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cellimm.2015.05.006","volume":"296","author":"GC Muller","year":"2015","unstructured":"Muller GC, Gottlieb MGV, Luz Correa B, Filho IG, Moresco RN, Bauer ME. The inverted CD4: CD8 ratio is associated with gender-related changes in oxidative stress during aging. Cell Immunol. 2015;296(2):149\u201354. https:\/\/doi.org\/10.1016\/j.cellimm.2015.05.006.","journal-title":"Cell Immunol"},{"issue":"2","key":"10054_CR113","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/cid\/ciw711","volume":"64","author":"I Rosado-S\u00e1nchez","year":"2017","unstructured":"Rosado-S\u00e1nchez I, Herrero-Fern\u00e1ndez I, Genebat M, Ruiz-Mateos E, Leal M, Pacheco YM. Thymic function impacts the peripheral CD4\/CD8 ratio of HIV-infected subjects. Clin Infect Dis. 2017;64(2):152\u20138. https:\/\/doi.org\/10.1093\/cid\/ciw711.","journal-title":"Clin Infect Dis"},{"key":"10054_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30236-8","author":"F Maffezzoni","year":"2020","unstructured":"Maffezzoni F, et al. Hypogonadism and bone health in men with HIV. Lancet HIV. 2020. https:\/\/doi.org\/10.1016\/S2352-3018(20)30236-8.","journal-title":"Lancet HIV"},{"key":"10054_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1892-5","author":"AR Gomes","year":"2016","unstructured":"Gomes AR, et al. Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy. BMC Infect Dis. 2016. https:\/\/doi.org\/10.1186\/s12879-016-1892-5.","journal-title":"BMC Infect Dis"},{"key":"10054_CR116","doi-asserted-by":"publisher","DOI":"10.1177\/135965350701200215","author":"DM Wunder","year":"2007","unstructured":"Wunder DM, et al. Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antivir Ther. 2007. https:\/\/doi.org\/10.1177\/135965350701200215.","journal-title":"Antivir Ther"},{"issue":"3","key":"10054_CR117","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/QAD.0000000000001348","volume":"31","author":"M Lach\u00e2tre","year":"2017","unstructured":"Lach\u00e2tre M, et al. HIV and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy. AIDS. 2017;31(3):451\u20133. https:\/\/doi.org\/10.1097\/QAD.0000000000001348.","journal-title":"AIDS"},{"issue":"1","key":"10054_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cit757","volume":"58","author":"JA Aberg","year":"2014","unstructured":"Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Executive summary: primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58(1):1\u201310. https:\/\/doi.org\/10.1093\/cid\/cit757.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10054_CR119","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s15010-020-01558-6","volume":"49","author":"LC Pezzaioli","year":"2021","unstructured":"Pezzaioli LC, et al. The importance of SHBG and calculated free testosterone for the diagnosis of symptomatic hypogonadism in HIV-infected men: a single-centre real-life experience. Infection. 2021;49(2):295\u2013303. https:\/\/doi.org\/10.1007\/s15010-020-01558-6.","journal-title":"Infection"},{"key":"10054_CR120","doi-asserted-by":"publisher","unstructured":"Zheng PM, Xie YQ, Lin SF, Zou L, Huang ZH, Zhang ZP. HIV patients\u2019 bone loss before and after antiretroviral treatment and its possible mechanisms, Apr. 01, 2023, Permanyer Publications. https:\/\/doi.org\/10.24875\/AIDSRev.22000028","DOI":"10.24875\/AIDSRev.22000028"},{"key":"10054_CR121","doi-asserted-by":"publisher","unstructured":"Chang CJ, Chan YL, Pramukti I, Ko NY, Tai TW. People with HIV infection had lower bone mineral density and increased fracture risk: a meta-analysis. Dec 01 2021 Springer Sci Bus Media Deutschland GmbH. https:\/\/doi.org\/10.1007\/s11657-021-00903-y","DOI":"10.1007\/s11657-021-00903-y"},{"issue":"2","key":"10054_CR122","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40618-021-01665-7","volume":"45","author":"LC Pezzaioli","year":"2022","unstructured":"Pezzaioli LC, et al. Impact of hypogonadism on bone mineral density and vertebral fractures in HIV-infected men. J Endocrinol Invest. 2022;45(2):433\u201343. https:\/\/doi.org\/10.1007\/s40618-021-01665-7.","journal-title":"J Endocrinol Invest"},{"key":"10054_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1516013","author":"L Chen","year":"2025","unstructured":"Chen L, et al. Bone loss in young adults with HIV following antiretroviral therapy containing Tenofovir disoproxil fumarate regimen using machine learning. Front Pharmacol. 2025. https:\/\/doi.org\/10.3389\/fphar.2025.1516013.","journal-title":"Front Pharmacol"},{"key":"10054_CR124","unstructured":"Waters L et al. BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 (2025 interim update) Writing group members."},{"key":"10054_CR125","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.24543","author":"RT Gandhi","year":"2025","unstructured":"Gandhi RT, et al. Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the International Antiviral Society-USA Panel. JAMA. 2025. https:\/\/doi.org\/10.1001\/jama.2024.24543.","journal-title":"JAMA"},{"key":"10054_CR126","doi-asserted-by":"publisher","unstructured":"Ambrosioni J, et al. Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025. HIV Med. 2026;27(1). https:\/\/doi.org\/10.1111\/hiv.70120.","DOI":"10.1111\/hiv.70120"},{"key":"10054_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0181-1","author":"JR Koethe","year":"2020","unstructured":"Koethe JR, et al. HIV and antiretroviral therapy-related fat alterations. Nat Rev Dis Primers. 2020. https:\/\/doi.org\/10.1038\/s41572-020-0181-1.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10054_CR128","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1007\/s40618-024-02375-6","volume":"47","author":"S De Vincentis","year":"2024","unstructured":"De Vincentis S, et al. Sarcopenic obesity and reduced BMD in young men living with HIV: body composition and sex steroids interplay. J Endocrinol Invest. 2024;47(11):2715\u201330. https:\/\/doi.org\/10.1007\/s40618-024-02375-6.","journal-title":"J Endocrinol Invest"},{"key":"10054_CR129","doi-asserted-by":"publisher","unstructured":"de Vincentis S, et al. Health status is related to testosterone, estrone and body fat: Moving to functional hypogonadism in adult men with HIV. Eur J Endocrinol. 2021;184(1). https:\/\/doi.org\/10.1530\/EJE-20-0855.","DOI":"10.1530\/EJE-20-0855"},{"key":"10054_CR130","doi-asserted-by":"publisher","unstructured":"Erlandson KM, et al. Inflammation, immune activation, immunosenescence, and hormonal biomarkers in the frailty-related phenotype of men with or at risk for HIV infection. J Infect Dis. Jan. 2017;215(2):228\u201337. https:\/\/doi.org\/10.1093\/infdis\/jiw523.","DOI":"10.1093\/infdis\/jiw523"},{"issue":"2","key":"10054_CR131","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/andr.310","volume":"3","author":"V Rochira","year":"2015","unstructured":"Rochira V, et al. Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study. Andrology. 2015;3(2):298\u2013308. https:\/\/doi.org\/10.1111\/andr.310.","journal-title":"Andrology"},{"issue":"1","key":"10054_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24875\/AIDSRev.21000018","volume":"24","author":"MVL Dos-Santos-quaresma","year":"2022","unstructured":"Dos-Santos-quaresma MVL, Lima-Ribeiro SM. Sarcopenia in persons living with HIV under antiretroviral therapy: literature review. AIDS Rev. 2022;24(1):1\u201315. https:\/\/doi.org\/10.24875\/AIDSRev.21000018.","journal-title":"AIDS Rev"},{"issue":"1","key":"10054_CR133","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jocd.2021.03.004","volume":"25","author":"NS Guimar\u00e3es","year":"2022","unstructured":"Guimar\u00e3es NS, Raposo MA, Greco D, Tupinamb\u00e1s U, Premaor MO. People living with HIV, lean mass, and sarcopenia: a systematic review and meta-analysis. J Clin Densitom. 2022;25(1):113\u201323. https:\/\/doi.org\/10.1016\/j.jocd.2021.03.004.","journal-title":"J Clin Densitom"},{"key":"10054_CR134","doi-asserted-by":"publisher","unstructured":"Wannamethee SG, Atkins JL. Muscle loss and obesity: The health implications of sarcopenia and sarcopenic obesity, in Proceedings of the Nutrition Society, Cambridge University Press, Nov. 2015, pp. 405\u2013412. https:\/\/doi.org\/10.1017\/S002966511500169X","DOI":"10.1017\/S002966511500169X"},{"key":"10054_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2023.02.018","author":"G Gortan Cappellari","year":"2023","unstructured":"Gortan Cappellari G, et al. Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) \u2013 proceedings from the SOGLI consortium meeting in Rome November 2022. Clin Nutr. 2023. https:\/\/doi.org\/10.1016\/j.clnu.2023.02.018.","journal-title":"Clin Nutr"},{"key":"10054_CR136","doi-asserted-by":"crossref","unstructured":"Baumgartner RN et al. Epidemiology of Sarcopenia among the Elderly in New Mexico,., 1998.","DOI":"10.1093\/oxfordjournals.aje.a009520"},{"key":"10054_CR137","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-015-0638-1","author":"E Poggiogalle","year":"2016","unstructured":"Poggiogalle E, et al. Sarcopenic obesity and metabolic syndrome in adult Caucasian subjects. J Nutr Health Aging. 2016. https:\/\/doi.org\/10.1007\/s12603-015-0638-1.","journal-title":"J Nutr Health Aging"},{"key":"10054_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-020-0637-0","author":"VHF Oliveira","year":"2020","unstructured":"Oliveira VHF, Borsari AL, Webel AR, Erlandson KM, Deminice R. Sarcopenia in people living with the Human Immunodeficiency Virus: a systematic review and meta-analysis. Eur J Clin Nutr. 2020. https:\/\/doi.org\/10.1038\/s41430-020-0637-0.","journal-title":"Eur J Clin Nutr"},{"key":"10054_CR139","first-page":"858","volume-title":"Handbook of Child Psychology","author":"DN Ruble","year":"2006","unstructured":"Ruble DN, Martin C, Berenbaum SA. Gender development. In: Eisenberg N, editor. in Handbook of Child Psychology. Volume 3. Hoboken, NJ: Wiley; 2006. pp. 858\u2013932."},{"key":"10054_CR140","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.20220334","author":"MB First","year":"2023","unstructured":"First MB, Clarke DE, Yousif L, Eng AM, Gogtay N, Appelbaum PS. DSM-5-TR: rationale, process, and overview of changes. Psychiatr Serv. 2023. https:\/\/doi.org\/10.1176\/appi.ps.20220334.","journal-title":"Psychiatr Serv"},{"issue":"S1","key":"10054_CR141","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","volume":"23","author":"E Coleman","year":"2022","unstructured":"Coleman E, et al. Standards of care for the health of Transgender and Gender Diverse People, Version 8,. Int J Transgend Health. 2022;23(S1):S1\u2013259. https:\/\/doi.org\/10.1080\/26895269.2022.2100644.","journal-title":"Int J Transgend Health"},{"issue":"11","key":"10054_CR142","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","volume":"102","author":"WC Hembree","year":"2017","unstructured":"Hembree WC, et al. Endocrine treatment of gender-dysphoric\/ gender-incongruent persons: An Endocrine Society\u2217clinical practice guideline,. J Clin Endocrinol Metab. 2017;102(11):3869\u2013903. https:\/\/doi.org\/10.1210\/jc.2017-01658.","journal-title":"J Clin Endocrinol Metab"},{"key":"10054_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00682-6","author":"K Wylie","year":"2016","unstructured":"Wylie K, Knudson G, Khan SI, Bonierbale M, Watanyusakul S, Baral S. Serving transgender people: clinical care considerations and service delivery models in transgender health. Lancet. 2016. https:\/\/doi.org\/10.1016\/S0140-6736(16)00682-6.","journal-title":"Lancet"},{"key":"10054_CR144","first-page":"341","volume-title":"Transgender Medicine, An Issue of Endocrinology and Metabolism Clinics of North America","author":"O Hamidi","year":"2019","unstructured":"Hamidi O, Davidge-Pitts CJ. Transfeminine hormone therapy. In: Tangpricha V, editor. in Transgender Medicine, An Issue of Endocrinology and Metabolism Clinics of North America. Volume 48, 1st ed. Philadelphia, PA: Elsevier; 2019. pp. 341\u201355.","edition":"1"},{"key":"10054_CR145","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae742","author":"S Khosla","year":"2025","unstructured":"Khosla S. The complex interplay of sex steroids and sex hormone-binding globulin in determining fracture risk in men. J Clin Endocrinol Metab. 2025. https:\/\/doi.org\/10.1210\/clinem\/dgae742.","journal-title":"J Clin Endocrinol Metab"},{"key":"10054_CR146","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf191","author":"M Tenuta","year":"2025","unstructured":"Tenuta M, Hasenmajer V, Gianfrilli D, Isidori AM. Testosterone and male bone health: a puzzle of interactions. J Clin Endocrinol Metab. 2025. https:\/\/doi.org\/10.1210\/clinem\/dgaf191.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10054_CR147","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/jbmr.3612","volume":"34","author":"CM Wiepjes","year":"2019","unstructured":"Wiepjes CM, et al. Bone safety during the first ten years of gender-affirming hormonal treatment in transwomen and transmen. J Bone Miner Res. 2019;34(3):447\u201354. https:\/\/doi.org\/10.1002\/jbmr.3612.","journal-title":"J Bone Miner Res"},{"key":"10054_CR148","doi-asserted-by":"publisher","unstructured":"Ceolin C, et al. Body composition and perceived stress levels in transgender individuals after one year of gender affirming hormone therapy. Front Endocrinol (Lausanne). 2024;15. https:\/\/doi.org\/10.3389\/fendo.2024.1496160.","DOI":"10.3389\/fendo.2024.1496160"},{"key":"10054_CR149","doi-asserted-by":"publisher","unstructured":"Van Caenegem E, et al. Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study. Osteoporos Int. Jan. 2015;26(1):35\u201347. https:\/\/doi.org\/10.1007\/s00198-014-2805-3.","DOI":"10.1007\/s00198-014-2805-3"},{"key":"10054_CR150","doi-asserted-by":"publisher","unstructured":"Singh-Ospina N et al. Effect of sex steroids on the bone health of transgender individuals: A systematic review and meta-analysis,., 2017, Oxford University Press. https:\/\/doi.org\/10.1210\/jc.2017-01642","DOI":"10.1210\/jc.2017-01642"},{"key":"10054_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2019.07.004","author":"HN Rosen","year":"2019","unstructured":"Rosen HN, et al. Bone densitometry in Transgender and Gender Non-Conforming (TGNC) individuals: 2019 ISCD official position. J Clin Densitom. 2019. https:\/\/doi.org\/10.1016\/j.jocd.2019.07.004.","journal-title":"J Clin Densitom"},{"key":"10054_CR152","doi-asserted-by":"publisher","unstructured":"Ceolin C et al. Feb., Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study, J. Endocrinol. Invest., vol. 47, no. 2, pp. 401\u2013410, 2024, https:\/\/doi.org\/10.1007\/s40618-023-02156-7","DOI":"10.1007\/s40618-023-02156-7"},{"key":"10054_CR153","doi-asserted-by":"publisher","unstructured":"Fighera TM, da Silva E, Lindenau JDR, Spritzer PM. Impact of cross-sex hormone therapy on bone mineral density and body composition in transwomen, Clin. Endocrinol. (Oxf)., vol. 88, no. 6, pp. 856\u2013862, Jun. 2018, https:\/\/doi.org\/10.1111\/cen.13607","DOI":"10.1111\/cen.13607"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10054-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-026-10054-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10054-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:29:14Z","timestamp":1784608154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-026-10054-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":153,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10054"],"URL":"https:\/\/doi.org\/10.1007\/s11154-026-10054-5","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"29 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"not applicable.","order":1,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}